Anaemetro I.V. Infusion 500mg Drug Use Investigation

Pfizer

Status: Completed

Conditions: Infectious Enterocolitis; Anaerobic Infection; Amebic Dysentery

Study type: Observational

Funder types: Industry

Identifiers

NCT03491228

A6831007

Details and patient eligibility

About

Secondary Data Collection Study; safety and effectiveness of Anaemetro under Japanese medical practice

Enrollment: 107 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who have not used metronidazole (injection) in the past, and have been given this drug for treatment of anaerobic infection, infectious enterocolitis, or amebic dysentery. Patients who have used metronidazole (oral agent and vaginal tablet) in the past are eligible, and should not be excluded from this study.

Exclusion criteria

• No exclusion criteria are set out in this study.

Trial design